Skip to main content
Researcher working with a microscope

License our intellectual property

Bring our innovations to market
We have a large portfolio of inventions available for licensing, commercialisation and investment.

Licensing our intellectual property (IP)

Our portfolio of inventions and innovations spans a number of sectors, including diagnostics, therapeutics, biomedical devices and optical technology, just to name a few.

We offer flexible licensing agreements, to streamline the process for our partner organisations.

If you’d like to find out more about the intellectual property we have available for licencing, or our range of licensing options, contact us on +61 2 9351 4000 or via our enquiry form.

Our commercial success stories

We're affiliated with a number of startups and new venture projects that have spun out from our technologies. 

Elastagen Pty Ltd is a clinical-stage medical device company that is pioneering Elastatherapy, which uses the human protein elastin to naturally repair and augment the skin.

The company has arisen out of patented research conducted by Professor Tony Weiss’s group and the first clinical trials have demonstrated the biocompatibility and safety of their synthetic human elastin in human subjects. 

Grok is the product of decades spent teaching high-school students, teachers and professionals how to program from scratch.

Professor Tara Murphy, Professor James Curran, Mr Tim Dawborn, and Dr Nicky Ringland founded Grok Learning in 2013. 

Pallas is an e-learning company with products for learning difficult STEM knowledge and skills through engaging game-like 3D experiences. The company has arisen out of research conducted by Professor Michael Jacobson from the Sydney School of Education and Social Work

Breathe Well is an interactive medical device company to assist lung cancer patients to breathe well, facilitating stable lung tumour motion for accurate radiation delivery during cancer treatment. The company was founded by Professor Paul Keall based on his work at the University of Sydney and Stanford University

Licensing and commercialisation news

Facts & figures

Our track record

  • 1100 patents filed in the past 20 years
  • 21 staff-led startups in the past 10 years
  • 19 commercialisation deals in 2018

Find a researcher

Search by name, area of expertise or faculty